A collaborative study, spearheaded by DIAMONDS consortium in King’s College London alongside Imperial College London and the University of Edinburgh, has revealed critical insights into immune dysfunction in children with severe infections and inflammatory diseases, such as multisystem inflammatory syndrome (MIS-C), severe bacterial infections, and Kawasaki disease.
Published in Nature Communications, the research involved an extensive analysis of immune cell profiles in 128 children, revealing key abnormalities in immune response.
These findings offer new potential for developing targeted therapies to improve outcomes for affected children.
This study, funded by the European Union and the UK’s NIHR, represents a major advancement in pediatric immunology. Researchers used advanced technologies to assess the immune cell composition and identified patterns that differentiate between severe bacterial infections and inflammatory syndromes. Such insights are crucial for clinicians aiming to deliver personalized treatments, optimizing the immune response in young patients with these serious conditions.
Read the full article here
